Literature DB >> 21790169

NSAIDs interactions with membranes: a biophysical approach.

Cláudia Nunes1, Gerald Brezesinski, Catarina Pereira-Leite, José L F C Lima, Salette Reis, Marlene Lúcio.   

Abstract

This work focuses on the interaction of four representative NSAIDs (nimesulide, indomethacin, meloxicam, and piroxicam) with different membrane models (liposomes, monolayers, and supported lipid bilayers), at different pH values, that mimic the pH conditions of normal (pH 7.4) and inflamed cells (pH 5.0). All models are composed of 1,2-dipalmitoyl-sn-glycero-3-phosphocholine (DPPC) which is a representative phospholipid of most cellular membranes. Several biophysical techniques were employed: Fluorescence steady-state anisotropy to study the effects of NSAIDs in membrane microviscosity and thus to assess the main phase transition of DPPC, surface pressure-area isotherms to evaluate the adsorption and penetration of NSAIDs into the membrane, IRRAS to acquire structural information of DPPC monolayers upon interaction with the drugs, and AFM to study the changes in surface topography of the lipid bilayers caused by the interaction with NSAIDs. The NSAIDs show pronounced interactions with the lipid membranes at both physiological and inflammatory conditions. Liposomes, monolayers, and supported lipid bilayers experiments allow the conclusion that the pH of the medium is an essential parameter when evaluating drug-membrane interactions, because it conditions the structure of the membrane and the ionization state of NSAIDs, thereby influencing the interactions between these drugs and the lipid membranes. The applied models and techniques provided detailed information about different aspects of the drug-membrane interaction offering valuable information to understand the effect of these drugs on their target membrane-associated enzymes and their side effects at the gastrointestinal level.
© 2011 American Chemical Society

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21790169     DOI: 10.1021/la201600y

Source DB:  PubMed          Journal:  Langmuir        ISSN: 0743-7463            Impact factor:   3.882


  13 in total

1.  Cyclooxygenase-2 catalysis and inhibition in lipid bilayer nanodiscs.

Authors:  Benjamin J Orlando; Daniel R McDougle; Michael J Lucido; Edward T Eng; Leigh Ann Graham; Claus Schneider; David L Stokes; Aditi Das; Michael G Malkowski
Journal:  Arch Biochem Biophys       Date:  2014-02-03       Impact factor: 4.013

2.  The shape/morphology balance: a study of stealth liposomes via fractal analysis and drug encapsulation.

Authors:  Natassa Pippa; Faidra Psarommati; Stergios Pispas; Costas Demetzos
Journal:  Pharm Res       Date:  2013-06-07       Impact factor: 4.200

3.  Insight into NSAID-induced membrane alterations, pathogenesis and therapeutics: characterization of interaction of NSAIDs with phosphatidylcholine.

Authors:  Lenard M Lichtenberger; Yong Zhou; Vasanthi Jayaraman; Janice R Doyen; Roger G O'Neil; Elizabeth J Dial; David E Volk; David G Gorenstein; Mohan Babu Boggara; Ramanan Krishnamoorti
Journal:  Biochim Biophys Acta       Date:  2012-04-14

Review 4.  Omega-3 polyunsaturated fatty acids as an angelus custos to rescue patients from NSAID-induced gastroduodenal damage.

Authors:  Jong Min Park; Young Min Han; Migyeong Jeong; Eun Hee Kim; Weon Jin Ko; Joo Young Cho; Ki Baik Hahm
Journal:  J Gastroenterol       Date:  2015-01-13       Impact factor: 7.527

5.  In vitro assessment of NSAIDs-membrane interactions: significance for pharmacological actions.

Authors:  Cláudia Nunes; Daniela Lopes; Marina Pinheiro; Catarina Pereira-Leite; Salette Reis
Journal:  Pharm Res       Date:  2013-05-24       Impact factor: 4.200

6.  Lipid Nanosystems and Serum Protein as Biomimetic Interfaces: Predicting the Biodistribution of a Caffeic Acid-Based Antioxidant.

Authors:  Eduarda Fernandes; Sofia Benfeito; Fernando Cagide; Hugo Gonçalves; Sigrid Bernstorff; Jana B Nieder; M Elisabete Cd Real Oliveira; Fernanda Borges; Marlene Lúcio
Journal:  Nanotechnol Sci Appl       Date:  2021-02-09

7.  Aspirin locally disrupts the liquid-ordered phase.

Authors:  Richard J Alsop; Sebastian Himbert; Alexander Dhaliwal; Karin Schmalzl; Maikel C Rheinstädter
Journal:  R Soc Open Sci       Date:  2018-02-28       Impact factor: 2.963

8.  Membrane-drug interactions studied using model membrane systems.

Authors:  Jacqueline Knobloch; Daniel K Suhendro; Julius L Zieleniecki; Joseph G Shapter; Ingo Köper
Journal:  Saudi J Biol Sci       Date:  2015-03-24       Impact factor: 4.219

9.  A Molecular Biophysical Approach to Diclofenac Topical Gastrointestinal Damage.

Authors:  Eduarda Fernandes; Telma B Soares; Hugo Gonçalves; Sigrid Bernstorff; Maria Elisabete C D Real Oliveira; Carla M Lopes; Marlene Lúcio
Journal:  Int J Mol Sci       Date:  2018-10-31       Impact factor: 5.923

10.  Licofelone-DPPC Interactions: Putting Membrane Lipids on the Radar of Drug Development.

Authors:  Catarina Pereira-Leite; Daniela Lopes-de-Campos; Philippe Fontaine; Iolanda M Cuccovia; Cláudia Nunes; Salette Reis
Journal:  Molecules       Date:  2019-01-31       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.